SENECTUS THERAPEUTICS

Senectus Therapeutics is a drug discovery company focused on the development of novel cancer therapies that target cellular senescence.

#SimilarOrganizations #Website #More

SENECTUS THERAPEUTICS

Industry:
Biotechnology Life Science Pharmaceutical

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.senectustherapeutics.co.uk

Status:
Closed

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Content Delivery Network Font Awesome LiteSpeed StackPath BootstrapCDN


Similar Organizations

invectys-therapeutics-logo

Invectys Therapeutics

Invectys Therapeutics is a biopharmaceutical company focused on the development of immunotherapy approaches to treat cancer.

not_available_image

Navion Pharma

Navion Pharma operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases.

orphion-therapeutics-logo

Orphion Therapeutics

Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.

Official Site Inspections

http://www.senectustherapeutics.co.uk

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Senectus Therapeutics"

Cancer therapies targeting cellular senescence Senectus …

Cancer therapies targeting cellular senescence Senectus TherapeuticsSee details»

Senectus Therapeutics - Crunchbase Company Profile & Funding

Organization. Senectus Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Senectus Therapeutics is a drug discovery …See details»

Senectus Therapeutics (Vimcad) - VentureRadar

Senectus Therapeutics (fka Vimcad) United Kingdom Privately Held Senectus Theraputics Ltd. is a drug discovery company focused on the development of novel therapeutics that target …See details»

Senectus Therapeutics - Products, Competitors, Financials, …

Senectus Therapeutics is a drug discovery company focused on the development of novel cancer therapies that target cellular senescence. Use the CB Insights Platform to explore Senectus …See details»

SENECTUS THERAPEUTICS LIMITED - Companies House

SENECTUS THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»

Senectus Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Oct 24, 2024 Explore Senectus Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Senectus Therapeutics - 2025 Company Profile - Tracxn

Feb 21, 2025 Senectus Therapeutics is a drug discovery company focused on the development of novel cancer therapies that target cellular senescence (cell ageing). In Mar 2011, Senectus …See details»

Senectus Therapeutics Limited - London E20 1JQ (Greater

SENECTUS THERAPEUTICS LIMITED offers research and experimental development on biotechnology. Incorporated in 2008 with the registration number 06600819, SENECTUS …See details»

SENECTUS THERAPEUTICS LIMITED | 06600819 - The Gazette

About SENECTUS THERAPEUTICS LIMITED. Company type: Private limited company Incorporated on: 22 May 2008 Nature of business (SIC): 72110 - Research and experimental …See details»

Senectus Therapeutics (fka Vimcad) - VentureRadar

Senectus Therapeutics (Vimcad) United Kingdom n/a?Created by Cancer Research Technologies, Senectus Therapeutics is a drug discovery and development venture focused …See details»

Senectus Therapeutics and AstraZeneca collaborate to identify …

Mar 23, 2011 Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing …See details»

Senectus Therapeutics - Crunchbase

Senectus Therapeutics is a drug discovery company focused on the development of novel cancer therapies that target cellular senescence. Search Crunchbase. Start Free Trial . Chrome …See details»

CRT and Cancer Research UK establish Lipid Metabolism Research …

Sep 29, 2011 This is the third of CRT’s consortia, the first called Senectus Therapeutics Ltd formed in 2008 to further research into the triggers of cellular senescence – cell aging- and in …See details»

SENECTUS THERAPEUTICS LIMITED - Companies House

People for SENECTUS THERAPEUTICS LIMITED (06600819) More for SENECTUS THERAPEUTICS LIMITED (06600819) Registered office address 2 Redman Place, London, …See details»

Cancer Research Technology and Cancer Research UK establish …

Jan 14, 2011 This is the second of CRT’s consortia, the first called Senectus Therapeutics Ltd formed in 2008 to further research into the triggers of cellular senescence – cell ageing - a …See details»

Senectus Therapeutics and AstraZeneca collaborate to identify …

Mar 23, 2011 In May 2009, Senectus Therapeutics Ltd., was incorporated as a ‘virtual company’ to directly manage any intellectual property generated by the consortium. Formation of …See details»

Senectus Therapeutics - Tech Stack, Apps, Patents & Trademarks

Senectus Therapeutics is a drug discovery company focused on the development of novel cancer therapies that target cellular senescence. Search Crunchbase. Start Free Trial . Chrome …See details»

Senectus therapeutics and Astrazeneca collaborate on tiggers to …

Mar 25, 2011 Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca's chemical compound library to identify those which trigger a key element of. English | Spanish. …See details»

Senectus Therapeutics Reviews | Read Client Reviews of Senectus ...

Read reviews of Senectus Therapeutics. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories For business Login or …See details»

Senectus Therapeutics and AstraZeneca Collaborate to Identify …

Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing – called …See details»

linkstock.net © 2022. All rights reserved